Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats

Journal of Chemical Neuroanatomy

Volumn 33, Issue 4, 2007, Pages 167-192

  Deng, Y P ^a   Xie, J P ^a   Wang, H B ^a   Lei, W L ^a,b   Chen, Q ^a   Reiner, A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

AMPA receptors; AMPA subunits; Excitotoxicity; Glutamate; Immunohistochemistry; Striatum

Indexed keywords

AMPA RECEPTOR; CALCIUM; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL MEMBRANE PERMEABILITY; CELL TYPE; CHEMICAL LABELING; CONTROLLED STUDY; DESENSITIZATION; EXCITOTOXICITY; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; INTERNEURON; LEARNING; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; STRIATE CORTEX; SUBSTANTIA NIGRA;

ACETYLCHOLINE; ANIMALS; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CORPUS STRIATUM; DENDRITIC SPINES; ENTOPEDUNCULAR NUCLEUS; FLUORESCENT ANTIBODY TECHNIQUE; GLOBUS PALLIDUS; GLUTAMIC ACID; INTERNEURONS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEOSTRIATUM; NEURAL PATHWAYS; NEURONAL PLASTICITY; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; SOMATOSTATIN;

EID: 34248551076     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2007.02.008     Document Type: Article

References (152)

1. Albin R.L., Reiner A., Anderson K.D., Dure IV L.S., Handelin B., Balfour R., Whetsell Jr. W.O., Penney J.B., and Young A.B. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann. Neurol. 31 (1992) 425-430
2. Albin R.L., Reiner A., Anderson K.D., Penney J.B., and Young A.B. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol. 27 (1990) 357-365
3. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12 (1989) 366-375
4. Albin R.L., Young A.B., Penney J.B., Handelin B., Balfour R., Anderson K.D., Markel D.S., Tourtellotte W.W., and Reiner A. Abnormalities of striatal projection neurons and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease. N. Engl. J. Med. 332 (1990) 1298-1923
5. Angulo M.C., Lambolez B., Audinat E., Hestrin S., and Rossier J. Subunit composition, kinetic, and permeation properties of AMPA receptors in single neocortical nonpyramidal cells. J. Neurosci. 17 (1997) 6685-6696
6. Aoki C., and Pickel V.M. Neuropeptide Y in the cerebral cortex and caudate-putamen nuclei: ultrastructural basis for interactions with GABAergic and non-GABAergic neurons. J. Neurosci. 9 (1989) 4333-4354
7. Aronica E.M., Gorter J.A., Grooms S., Kessler J.A., Bennett M.V.L., Zukin R.S., and Rosenbaum D.M. Aurintricarboxylic acid prevents GluR2 mRNA down-regulation and delayed neurodegeneration in hippocampal CA1 neurons of gerbil after global ischemia. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7115-7120
8. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., and Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15 (1995) 3328-3341
9. Bazzett T.J., Becker J.B., Katz K.W., and Albin R.L. Chronic intrastriatal dialytic administration of quinolinc acid produces selective neural degeneration. Exp. Neurol. 120 (1993) 177-185
10. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., and Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321 (1986) 168-171
11. Beal M.F., Ferrante R.J., Swartz K.J., and Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11 (1991) 1649-1659
12. Bennett B.D., and Bolam J.P. Characterization of calretinin-immunoreactive structures in the striatum of the rat. Brain Res. 609 (1993) 137-148
13. Bennett B.D., Callaway J.C., and Wilson C.J. Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons. J. Neurosci. 20 (2000) 8493-8503
14. Bernard V., Gardiol A., Faucheux B., Bloch B., Agid Y., and Hirsch E.C. Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion. J. Comp. Neurol. 368 (1996) 553-568
15. Bernard V., Somogyi P., and Bolam J.P. Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J. Neurosci. 17 (1997) 819-833
16. Blaschke M., Keller B.U., Rivosecchi R., Hollmann M., Heinemann S., and Konnerth A. A single amino acid determines the subunit-specific spider toxin block of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor channels. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6528-6532
17. Bruce G., Wainer B.H., and Hersh L.B. Immunoaffinity purification of human choline acetyltransferase: comparison of the brain and placental enzymes. J. Neurochem. 45 (1985) 611-620
18. Burke R.E., and Baimbridge K.G. Relative loss of the striatal striosome compartment, defined by calbindin-D28k immunostaining, following developmental hypoxic-ischemic injury. Neuroscience 56 (1993) 305-315
19. Burnashev N., Monyer H., Seeburg P.H., and Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8 (1992) 189-198
20. Calabresi P., Centonze D., Pisani A., Sancesario G., Gubellini P., Marfia G.A., and Bernardi G. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Ann. Neurol. 43 (1998) 586-597
21. Carlson N.G., Howard J., Gahring L.C., and Roger S.W. RNA editing (Q/R site) and flop/flip splicing of AMPA receptor transcripts in young and old brains. Neurobiol. Aging 21 (2000) 599-606
22. Carter A.G., and Sabatini B.L. State-dependent calcium signaling in dendritic spines of striatal medium spiny neurons. Neuron 44 (2004) 483-493
23. Catania M.V., Tolle T.R., and Monyer H. Differential expression of AMPA receptor subunits in NOS-positive neurons of cortex, striatum, and hippocampus. J. Neurosci. 15 (1995) 7046-7061
24. Celio M.R. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35 (1990) 375-475
25. Celio M.R., Baier W., Scharer L., de Viragh P.A., and Gerday C. Monoclonal antibodies directed against the calcium binding protein parvalbumin. Cell Calcium 9 (1988) 81-86
26. Celio M.R., Baier W., Scharer L., Gregersen H.J., de Viragh P.A., and Norman A.W. Monoclonal antibodies directed against the calcium binding protein Calbindin D-28k. Cell Calcium 11 (1990) 599-602
27. Chen Q., Harris C., Brown C.S., Howe A., Sumeier D.J., and Reiner A. Glutamate-mediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors. Exp. Neurol. 136 (1995) 212-224
28. Chen Q., Veenman C.L., and Reiner A. Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity. Neuroscience 73 (1996) 715-731
29. Chen Q., Veenman C.L., Knopp K., Yan Z., Medina L., Song W.J., Surmeier D.J., and Reiner A. Evidence for the preferential localization of GluR1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum. Neuroscience 83 (1998) 749-761
30. Chen Q., Surmeier D.J., and Reiner A. NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization. Exp. Neurol. 159 (1999) 283-296
31. Chesselet M.F., Lin C.S., Polsky K., and Jin B.K. Ischemic damage in the striatum of adults gerbils: relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons. Exp. Neurol. 110 (1990) 209-218
32. Cicchetti F., Gould P.V., and Parent A. Sparing of striatal neurons coexpressing calretin and substance P (NK-1) receptor in Huntington's disease. Brain Res. 730 (1996) 232-237
33. Cicchetti F., and Parent A. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium sized neuron. Mov. Disord. 11 (1996) 619-626
34. Cicchetti F., Prensa L., Wu Y., and Parent A. Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease. Brain Res. Rev. 34 (2000) 80-101
35. Cicchetti F., Vinet J., Beach T.G., and Parent A. Differential expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits by calretinin immunoreactive neurons in the human striatum. Neuroscience 93 (1999) 89-97
36. Cowan R.H., and Wilson C.J. Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex. J. Neurophysiol. 71 (1994) 17-32
37. Dawbarn D., DeQuidt M.E., and Emson P.C. Survival of basal ganglia neuropeptide Y-somatostatin neurons in Huntington's disease. Brain Res. 340 (1985) 251-260
38. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13 (1990) 281-285
39. Deng Y.P., Albin R.L., Penney J.B., Young A.B., Anderson K.D., and Reiner A. Differential loss of striatal projection neurons in Huntington's disease: a quantitative immunohistochemical study. J. Chem. Neuroanat. 27 (2004) 143-164
40. Deng Y.P., Lei W.L., and Reiner A. Differential perikayal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J. Chem. Neuroanat. 32 (2006) 101-116
41. Desban M., Kemel M.L., Glowinski J., and Gauchy C. Spatial organization of patch and matrix compartments in the rat striatum. Neuroscience 57 (1993) 661-667
42. DiFiglia M. Excitotoxic injury of the striatum: a model for Huntington's disease. Trends Neurosci. 13 (1990) 286-289
43. Feldmeyer D., Kask K., Brusa R., Kornau H.C., Kolhekar R., Rozov A., Burnashev N., Jensen V., Hvalby O., Spremgel R., and Seeburg P.H. Neurological dysfunctions in mice expressing different levels of the Q/R site-edited AMPAR subunit GluR-B. Nat. Neurosci. 1 (1999) 57-64
44. Ferrante R.J., Beal M.F., Kowall N.W., Richardson E.P., and Martin Jr. J.B. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res. 411 (1987) 162-166
45. Ferrante R.J., Kowall N.W., Beal M.F., Martin J.B., Bird E.D., and Richardson Jr. E.P. Morphological and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 46 (1987) 12-27
46. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P., Bird E.D., and Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science 230 (1985) 561-563
47. Ferrer I., Kulisevsky J., Gonzalez G., Escartin A., Chivite A., and Casas R. Parvalbumin-immunoreactive neurons in cerebral cortex and striatum in Huntington's disease. Neurodegeneration 3 (1994) 169-173
48. Figueredo-Cardenas G., Anderson K.D., Chen Q., Veenman C.L., and Reiner A. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats. Exp. Neurol. 129 (1994) 37-56
49. Figueredo-Cardenas G., Morello M., Sancesario G., Bernardi G., and Reiner A. Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res. 735 (1996) 317-324
50. Figueredo-Cardenas G., Medina L., and Reiner A. Calretinin is localized to a unique population of striatal interneurons in rats. Brain Res. 709 (1996) 145-150
51. Figueredo-Cardenas G., Chen Q., and Reiner A. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats. Exp. Neurol. 146 (1997) 444-457
52. Figueredo-Cardenas G., Harris C.L., Anderson K.D., and Reiner A. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types. Exp. Neurol. 149 (1998) 356-372
53. Fortin M., and Parent A. Patches in the striatum of squirrel monkeys are enriched with calretinin fibers but devoid of calretinin cell bodies. Neurosci. Lett. 182 (1994) 51-54
54. Fusco F.R., Chen Q., Lamoreaux W.J., Figueredo-Cardenas G., Jiao Y., Coffman J.A., Surmeier D.J., Honig M.G., Carlock L.R., and Reiner A. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J. Neurosci. 19 (1999) 1189-1202
55. 2+ permeability of AMPA receptors in principal neurons and interneurons in the rat CNS. Neuron 15 (1995) 193-204
56. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann. Rev. Neurosci. 15 (1992) 285-320
57. Gerfen C.R., and Wilson C.J. The basal ganglia. In: Swanson L.W., Bjoklund A., and Hokfelt T. (Eds). Handbook of Chemical Neuroanatomy, vol. 12, Integrated System of the CNS. Part 3 (1996), Elsevier, Amsterdam 371-468
58. Glass M., Dragunow M., and Faull R.L.M. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannobinoid, dopamine, adenosine and GABAa receptor alterations in the human basal ganglia in Hunting's disease. Neuroscience 97 (2000) 505-519
59. Götz T., Kraushaar U., Geiger J., Lubke J., Berger T., and Jonas P. Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J. Neurosci. 17 (1997) 204-215
60. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13 (1990) 244-254
61. Hathway G.J., Humphrey P.P., and Kendrick K.M. Somatostatin release by glutamate in vivo is primarily regulated by AMPA receptors. Br. J. Pharmacol. 134 (2001) 1155-1158
62. Hawker K., and Lang A.E. Hypoxic-ischemic damage of the basal ganglia: case reports and a review of the literature. Mov. Disord. 5 (1990) 219-224
63. Hedreen J.C., and Folstein S. Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54 (1995) 105-120
64. Hendry S.H., Jones E.G., DeFelipe J., Schmechel D., Brandon C., and Emson P.C. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 6526-6530
65. Herlitze S., Raditsch M., Ruppersberg J.P., Jahn W., Monyer H., Schoepfer R., and Witzemann V. Argiotoxin detects molecular differences in AMPA receptor channels. Neuron 10 (1993) 1131-1140
66. Hollmann M., and Heinemann S. Cloned glutamate receptors. Ann. Rev. Neurosci. 17 (1994) 31-108
67. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252 (1991) 851-853
68. Iihara K., Joo D.T., Henderson J., Sattlaer R., Taverna F.A., Lourensen S., Orser B.A., Rodeer J.C., and Tymianski M. The influence of glutamate receptor 2 expression on excitotoxicity in GluR2 null mutant mice. J. Neurosci. 21 (2001) 2224-2239
69. Ikonomidou C., and Turski L. Neurodegenerative disorders: clues from glutamate and energy metabolism. Crit. Rev. Neurobiol. 10 (1996) 239-263
70. Jog M.S., Kubota Y., Connolly C.I., Hillegaart V., and Graybiel A.M. Building neural representations of habits. Science 286 (1999) 1745-1749
71. Jonas P., and Burnashev N. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron 15 (1995) 987-990
72. 2+ permeability of APMA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron 12 (1994) 1281-1289
73. 2+-binding parvalbumin in rat testis. Characterization, localization, and expression during development. J. Biol. Chem. 262 (1987) 7314-7320
74. Kawaguchi Y., Wilson C.J., and Emson P.C. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci. 10 (1990) 3238-3421
75. Kawaguchi Y. Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J. Neurosci. 13 (1993) 4908-4923
76. Kawaguchi Y., Wilson C.J., Augood S.J., and Emson P.C. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci. 18 (1995) 527-535
77. Keinanen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A., Sakamann B., and Seeberg P.H. A family of AMPA-selective glutamate receptors. Science 249 (1990) 556-560
78. Kim D.Y., Kim S.H., Choi H.B., Min C., and Gwag B.J. High abundance of GluR1 mRNA and reduced Q/R editing of GluR2 mRNA in individual NADPH-diaphorase neurons. Mol. Cell Neurosci. 17 (2001) 1025-1033
79. Kincaid A.E., and Wilson C.J. Corticostriatal innervation of the patch and matrix in the rat neostriatum. J. Comp. Neurol. 374 (1996) 578-592
80. Kita H. GABAergic circuits of the striatum. Prog. Brain Res. 99 (1993) 51-72
81. Kita H. Glutamatergic and GABAergic postsynaptic responses of striatal spiny neurons to intrastriatal and cortical stimulation recorded in slice preparations. Neuroscience 70 (1996) 925-940
82. Kita H., Kosaka T., and Heizmann C.W. Parvalbumin-immunoreactive neurons in the rat neostriatum: a light and electron microscopic study. Brain Res. 536 (1990) 1-15
83. long-containing AMPA receptors. Neuron 40 (2003) 1199-1212
84. Kondo M., Sumino R., and Okado H. Combinations of AMPA subunit expression in individual cortical neurons correlate with expression of specific calcium-binding proteins. J. Neurosci. 17 (1997) 1570-1581
85. Koos T., and Tepper J.M. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat. Neurosci. 2 (1999) 467-472
86. Kowall N.W., Ferrante R.J., and Martin J.B. Pattern of cell loss in Huntington's disease. Trends Neurosci. 10 (1987) 24-29
87. Kubota Y., Mikawa S., and Kawaguchi Y. Neostriatal GABAergic interneurons contain NOS, calretinin or parvalbumin. NeuroReport 5 (1993) 205-208
88. Kwok K.H.H., Tse Y.C., Wong R.N.S., and Yung K.K.L. Cellular localization of GluR1, GluR2/3 and GluR4 glutamate receptor subunits in neurons of the rat neostriatum. Brain Res. 778 (1997) 43-55
89. Lapper S.R., and Bolam J.P. Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroscience 51 (1992) 533-545
90. Lapper S.R., Smith Y., Sadikot A.F., Parent A., and Bolam J.P. Cortical input to parvalbumin-immunoreactive neurones in the putamen of the squirrel monkey. Brain Res. 580 (1992) 215-224
91. Le D., Das S., Wang Y.F., Yoshizawa T., Sasaki Y.F., Takasu M., Nemes A., Mendelsohn M., Dikkes P., Lipton S.A., and Nakanishi N. Enhanced neuronal death from focal ischemia in AMPA-receptor transgenic mice. Mol. Brain Res. 52 (1997) 235-241
92. Lei W.L., Jiao Y., Del Mar N., and Reiner A. Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J. Neurosci. 24 (2004) 8289-8299
93. Lomeli H., Mosbacher J., Melcher T., Hoger T., Geiger J.R., Kuner T., Monyer H., Higuchi M., Bach A., and Seeburg P.H. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266 (1994) 1709-1713
94. Martin L.J., Blackstone C.D., Huganir R.L., and Price D.L. The striatal mosaic in primates: striasomes and matrix are differentially enriched in ionotropic glutamate receptor subunits. J. Neurosci. 13 (1993) 782-792
95. Martin L.J., Blackstone C.D., Levey A.I., Huganir R.L., and Price D.L. AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53 (1993) 327-358
96. Meade C.A., Deng Y.P., Fusco F.R., Del Mar N., Hersch S., Goldowitz D., and Reiner A. Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J. Comp. Neurol. 449 (2002) 241-269
97. Meade C.A., Figueredo-Cardenas G., Fusco F., Nowak Jr. T.S., Pulsinelli W.A., and Reiner A. Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease. Exp. Neurol. 166 (2000) 307-323
98. Meng S.Z., Obonai T., Isumi H., and Takashima S. A developmental expression of AMPA-selective glutamate receptor subunits in human basal ganglia. Brain Dev. 19 (1997) 388-392
99. Ono M., Murakami T., Kudo A., Isshiki M., Sawada H., and Segawa A. Quantitative comparison of anti-fading mounting media for confocal laser scanning microscopy. J. Histochem. Cytochem. 49 (2001) 305-311
100. Panchuk-Voloshina N., Haugland R.P., Bishop-Stewart J., Bhalgat M.K., Millard P.J., Mao F., Leung W.Y., and Haugland R.P. Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J. Histochem. Cytochem. 47 (1999) 1179-1188
101. Parent A., Cicchetti F., and Beach T.G. Calretinin-immunoreactive neurons in the human striatum. Brain Res. 674 (1995) 347-351
102. Paschen W. Glutamate excitotoxicity in transient global cerebral ischemia. Acta Neurobiol. Exp. 56 (1996) 313-322
103. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. (1998), Academic Press, New York
104. 2+-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20 (1997) 464-470
105. Pellegrini-Giampietro D.E., Zukin R.S., Bennett M.V., Cho S., and Pulsinelli W.A. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10499-10503
106. Petralia R.S., and Wenthold R.J. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J. Comp. Neurol. 318 (1992) 329-354
107. Plant K., Pelkey K.A., Bortolotto Z.A., Morita D., Terashima A., McBain C.J., Collingridge G.L., and Isaac J.T.R. Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation. Nat. Neurosci. 9 (2006) 602-604
108. 2A receptor reduces, through a presynatpic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative disease of the striatum. J. Neurosci. 22 (2002) 1967-1975
109. Prensa L., Gimenez-Agaya J.M., and Parent A. Morphological features of neurons containing calcium binding proteins in the human striatum. J. Comp. Neurol. 390 (1998) 552-563
110. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., and Young A.B. Differential loss of striatal projection neurons in Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5733-5737
111. Reiner A., and Anderson K.D. The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings. Brain Res. Rev. 15 (1990) 251-265
112. Reiner A., Veenman C.L., Medina L., Jiao Y., Del Mar N., and Honig M.G. Pathway tracing using biotinylated dextran amines. J. Neurosci. Methods 103 (2000) 23-37
113. Reiner A., Jiao Y., Del Mar N., Laverghetta A.V., and Lei W.L. Differential morphology of pyramidal-tract type and intratelencephalically-projecting type corticostriatal neurons and their intrastriatal terminals in rats. J. Comp. Neurol. 457 (2003) 420-440
114. Richardson P.J., Dixon A.K., Lee K., Bell M.I., Cox P.J., Williams R., Pinnock R.D., and Freeman T.C. Correlating physiology with gene expression in striatal cholinergic neurones. J. Neurochem. 74 (2000) 839-846
115. Richfield E.K., Maguire-Zeiss K.A., Cox C., Gilmore J., and Voorn P. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients. Ann. Neurol. 37 (1995) 335-343
116. Rogers S.W., Hughes T.E., Hollmann M., Gasic G.P., Deneris E.S., and Heinemann S. The characterization and localization of the glutamate receptor subunit GluR1 in the rat brain. J. Neurosci. 11 (1991) 2713-2724
117. Sapp E., Ge P., Aizawa H., Bird E., Penney J., Young A.B., von Sattel J.P., and DiFiglia M. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 64 (1995) 397-404
118. Sato K., Kiyama H., and Tohyama M. The differential expression patterns of messenger RNAs encoding non-N-methyl-d-aspartate glutamate receptor subunits (GluR1-4) in the rat brain. Neuroscience 52 (1993) 515-539
119. Schwarcz R.A.C., Foster E.D., French W.O., Whetsell Jr., and Kohler C. Excitoxic models for neurodegenerative disorders. Life Sci. 35 (1984) 19-32
120. Schwaller B., Buchwald P., Blumcke I., Celio M.R., and Hunziker W. Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium 14 (1993) 639-648
121. Seidenman K.J., Steinberg J.P., Huganir R., and Malinow R. Glutamate receptor subunit 2 serine 880 phosphorylation modulates synaptic transmission and mediates plasticity in CA1 pyramidal cells. J. Neuroci. 23 (2003) 9220-9228
122. Seto-Ohshima A., Emson P.C., Lawson E., Mountjoy C.Q., and Carrasco L.H. Loss of matrix calcium-binding protein-containing neurons in Huntington's disease. Lancet 1 8597 (1988) 1252-1255
123. Shiromani P.J., Armstrong D.M., Bruce G., Hersh L.B., Groves P.M., and Gillin J.C. Relation of pontine choline acetyltransferase immunoreactive neurons with cells which increase discharge during REM sleep. Brain Res. Bull. 18 (1987) 447-455
124. Somogyi P., Bolam J.P., and Smith A.D. Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-peroxidase transport-degeneration procedure. J. Comp. Neurol. 195 (1981) 567-584
125. Song I., and Huganir R. Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci. 25 (2002) 578-588
126. Stefani A., Chen Q., Flores-Hernandez J., Jiao Y., Reiner A., and Surmeier D.J. Physiological and molecular properties of AMPA/KA receptors expressed by striatal medium spiny neurons. Dev. Neurosci. 20 (1998) 242-252
127. Swanson G.T., Kamboj S.K., and Cull-Candy S.G. Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition. J. Neurosci. 17 (1997) 58-69
128. Tallaksen-Greene S.J., and Albin R.L. Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons. Neuroscience 61 (1994) 509-519
129. Tallaksen-Greene S.J., and Albin R.L. Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons. Neuroscience 75 (1996) 1057-1064
130. Terashima A., Cotton L., Dev K.K., Meyer G., Zaman S., Duprat F., Henley J.M., Collingridge G.L., and Isaac J.T.R. Regulation of synaptic strength and AMPA receptor subunit composition by PICK1. J. Neurosci. 24 (2004) 5381-5390
131. Tsubokawa H., Oguro K., Masuzawa T., and Kawai N. Ca(2+)-dependent non-NMDA receptor-mediated synaptic currents in ischemic CA1 hippocampal neurons. J. Neurophysiol. 71 (1994) 1190-1196
132. Uemura Y., Kowall N.W., and Beal M.F. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann. Neurol. 27 (1990) 620-625
133. Van Damme P., Van Den Bosch L., Van Houtte E., Callewaert G., and Robberrecht W. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. J. Neurophysiol. 88 (2002) 1279-1287
134. 2+-permeable AMPA receptors and selective vulnerability of motor neurons. J. Neurol. Sci. 180 (2000) 29-34
135. Vandenberghe W., Robberecht W., and Brorson J.R. AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. J. Neurosci. 20 (2000) 123-132
136. Vincent S.R., and Johansson O. Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscopic study. J. Comp. Neurol. 217 (1983) 264-270
137. Vissavajjhala P., Janssen W.G.M., Hu Y., Gazzaley A.M., Moran T., Hof P.R., and Morrison J.H. Synaptic distribution of the AMPA-GluR2 subunit and its colocalization with calcium-binding proteins in rat cerebral cortex: an immunohistochemical study using a GluR2-specific monoclonal antibody. Exp. Neurol. 142 (1996) 296-312
138. Vonsattel J.-P., and DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57 (1998) 369-384
139. Vonsattel J.-P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44 (1985) 559-577
140. Vorobjev V.S., Sharonova I.N., Haas H.L., and Sergeeva O.A. Differential modulation of AMPA receptors by cyclothiazide in two types of striatal neurons. Eur. J. Neurosci. 12 (2000) 2871-2880
141. Vuillet J., Kerkerian L., Kachidian P., Bosler O., and Nieoullon A. Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum. Neurosci. Lett. 100 (1989) 99-104
142. Wang H., and Pickel V. Dendritic spines containing μ-opioid receptors in rat striatal patches receive asymmetric synapses from prefrontal corticostriatal afferents. J. Comp. Neurol. 396 (1998) 223-237
143. Wang H.B., Laverghetta A.V., Foehring R., Deng Y.P., Sun Z., Yamamoto K., Lei W.L., Jiao Y., and Reiner A. Single-cell RT-PCR, in situ hybridization histochemistry, and immunohistochemical studies of substance P and enkephalin co-occurrence in striatal projection neurons in rats. J. Chem. Neuroanat. 31 (2006) 178-199
144. Washburn M.S., Numberger M., Zhang S., and Dingledine R. Differential dependence on GluR2 expression of three characteristic features of AMPA receptors. J. Neurosci. 17 (1997) 9393-9406
145. Wenthold R.J., Yokotani N., Doi K., and Wada K. Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies. Evidence for a hetero-oligomeric structure in rat brain. J. Biol. Chem. 267 (1992) 501-507
146. Wilson C.J. Morphology and synaptic connections of crossed corticostriatal neurons in the rat. J. Comp. Neurol. 263 (1987) 567-580
147. Wilson C.J. Basal ganglia. In: Shepard G.M. (Ed). The Synaptic Organization of the Brain (1990), Oxford University Press, New York 279-316
148. Wilson C.J. Dendritic morphology, inward rectification and the functional properties of neostriatal neurons. In: McKenna T., Davis J., and Kornetzer S.F. (Eds). Single Neuron Computation (1992), Academic Press, San Diego 141-171
149. Wilson C.J. The contribution of cortical neurons to the firing pattern of striatal spiny neurons. In: Houk J.C., Davis J.L., and Beiser D.G. (Eds). Models of Information Processing in the Basal Ganglia (1995), MIT Press, Cambridge, Massachusetts 29-50
150. Wright A.K., Ramanathan S., and Arbuthnott G.W. Identification of the source of the bilateral projection system from cortex to somatosensory neostriatum and an exploration of its physiological actions. Neuroscience 103 (2001) 87-96
151. Wu Y., Richard S., and Parent A. The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci. Res. 38 (2000) 49-62
152. 2+-binding status and differences in antigen accessibility in colon cancer cells. Cell Calcium 31 (2002) 13-25